Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22.Increased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophrenia -- Juntendo University Schizophrenia Projects (JUSP)No genetic association between ATP binding cassette proteins and Japanese sporadic Alzheimer's diseasePlasma alanine levels increase in patients with schizophrenia as their clinical symptoms improve-Results from the Juntendo University Schizophrenia Projects (JUSP)Brain perfusion in fibromyalgia patients and its differences between responders and poor responders to gabapentin.No genetic association between PCSK9 polymorphisms and Alzheimer's disease and plasma cholesterol level in Japanese patients.Association analysis of glycine- and serine-related genes in a Japanese population of patients with schizophrenia.Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p.No genetic association between Fyn kinase gene polymorphisms (-93A/G, IVS10+37T/C and Ex12+894T/G) and Japanese sporadic Alzheimer's disease.Expression of nNOS and soluble guanylate cyclase in schizophrenic brain.Significance of measurements of peripheral carbonyl stress markers in a cross-sectional and longitudinal study in patients with acute-stage schizophrenia.Meta-analysis of the association between variants in SORL1 and Alzheimer disease.Genetic Association between Akt1 Polymorphisms and Alzheimer's Disease in a Japanese PopulationSerum brain-derived neurotrophic factor levels and personality traits in patients with major depressionDiagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study.Association between DNA Methylation of the BDNF Promoter Region and Clinical Presentation in Alzheimer's Disease.Haloperidol plasma concentration in Japanese psychiatric subjects with gene duplication of CYP2D6.Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer's Disease and Amnesic Mild Cognitive ImpairmentHypothesis: minimal changes in neural transmission in schizophrenia: decreased glutamatergic and GABAergic functions in the prefrontal cortex.Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer's Disease and Amnestic Mild Cognitive ImpairmentCase reports and literature review: the association between reactivation of human herpes virus-6 and peripheral white blood cell count in patients with carbamazepine-induced hypersensitivity syndrome.Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer's disease: a prospective, open-label pilot studyNo Associations Found between PGBD1 and the Age of Onset in Japanese Patients Diagnosed with Sporadic Alzheimer's DiseaseAge-Related Association between Apolipoprotein E ε4 and Cognitive Function in Japanese Patients with Alzheimer's DiseaseGenetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese Population.Lack of Genetic Associations of PPAR-γ and PGC-1α with Alzheimer's Disease and Parkinson's Disease with Dementia.Genetic Association between Neurotrophin-3 Polymorphisms and Alzheimer's Disease in Japanese PatientsAbnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in lewy body disease.Pulmonary embolism from persistent dilatation of the bladder secondary to anticholinergic side effects.Significance of NMDA receptor-related glutamatergic amino acid levels in peripheral blood of patients with schizophrenia.Neuropathological investigation of regions responsible for semantic aphasia in frontotemporal lobar degeneration.Temperament and character as predictors of recurrence in remitted patients with major depression: a 4-year prospective follow-up study.Simultaneous resting-state functional MRI and electroencephalography recordings of functional connectivity in patients with schizophrenia.Psychomotor agitation in major depressive disorder is a predictive factor of mood-switching.Metabolism of amyloid-β protein may be affected in depression.Genetic association between clusterin polymorphisms and Alzheimer's disease in a Japanese population.Psychiatric and psychological outcomes of Japanese living donors following liver transplantation.Requirement of tryptophan hydroxylase during development for maturation of sensorimotor gating.Recurrent cholecystitis in an elderly mentally retarded patient with pica.Associations of common copy number variants in glutathione S-transferase mu 1 and D-dopachrome tautomerase-like protein genes with risk of schizophrenia in a Japanese population.
P50
Q24536203-F2F642AC-00E1-46D9-B432-7F8D52A45C3DQ28238917-083E13A2-48D1-4FAA-A56A-752BC55977BEQ28258393-2D7BCD80-0404-4DBC-ADEF-85982D9EB422Q28275896-E9C21F96-E4EE-4877-A47E-F22FB83D0C73Q33923430-E5AE607A-CEC6-497C-85B2-A436B483326DQ33991719-027B1613-F0C1-4EE8-8E89-34FAB27C64E3Q34016178-402DD7B0-E786-4132-82B8-5C3EE31BBAF8Q34137538-22DB05BE-A619-46DC-A658-BEEF612ADC59Q34313122-2C330EB6-74F9-4631-A27E-E05886FD46F2Q34314643-EB24D1F7-0B54-4607-ACDF-F8E267A5C10DQ34322948-46E83F48-E3C4-4FA1-B6D4-11D04003FA0AQ34913294-548975C9-531A-4CCF-B6D7-2CD2AD13E048Q35113832-79B37FA1-543C-4755-97D6-343933466CF5Q35162627-F3B182D7-67C6-4EE2-803E-990CA6E186EFQ35203115-2CFA1132-71F4-45A6-B17F-6255CBE0896BQ35225338-196D5081-2CBA-4E0A-80C2-7997F9FFA6A4Q35825671-25045A5C-92C8-482B-A5BA-D0B9F2BAD8A6Q35888210-B1AF99AA-DD32-4249-AFDE-3231CB76FD6BQ36159544-19A71D10-0E79-4A05-8C4F-F870D4A7A1C0Q36228525-FDD860DD-5276-4F5F-B37D-D5D0AFEF2EDEQ36432978-BEB498DF-A4C7-4DAE-8C94-F9E3ECDB12CFQ36462966-E8040F51-2AC7-4E7B-9990-29D6D36BEB82Q36467254-59170ED2-EB26-4CDD-8EA6-7819AB416988Q36744473-979ADD18-7005-4159-9ED1-5AFFE37E6E9AQ36766239-196397DF-75E6-4049-B1BB-F4A017830883Q36896649-A969C137-4F8C-4761-B672-EF90037BE89FQ37255118-4622BF9D-222B-4750-92EA-5031B4EB8E87Q37402225-89876853-DBA2-44E3-ABE8-CFFD72B0FCFFQ37408856-B7840DC3-AC61-465B-BF27-FACAAFBB531DQ37786690-81461DB4-D703-4EE1-9D56-DA7D80B37636Q38383619-F19D4C41-2A87-46DB-80D2-4922A87AD560Q39064260-7ECB08D1-00CF-4EB8-9FB6-88C8E0ABAA94Q39093056-B59D6CAE-88F6-4F25-9CA1-798C6D8490CAQ39124631-0BFD6401-9478-4FE0-99A2-966B7F65AB9DQ39677668-D5926C07-CF83-4599-90F9-9220C881D406Q39766608-39F24756-6278-4E12-B515-8A9922E4C4CBQ39970577-DF663B48-CCFB-4248-8509-21176D7C247CQ40231198-B30A3E9C-1B7D-45A3-874B-173637E223DFQ40303433-A6454171-9D7C-456E-9AD3-DC22ED88A705Q40736341-F47ABF88-9FE5-474C-9186-EAE77E6869BD
P50
description
psychiater
@nl
name
Heii Arai
@ast
Heii Arai
@en
Heii Arai
@es
Heii Arai
@fr
Араи, Хэйи
@ru
新井平伊
@ja
type
label
Heii Arai
@ast
Heii Arai
@en
Heii Arai
@es
Heii Arai
@fr
Араи, Хэйи
@ru
新井平伊
@ja
altLabel
Хэйи Араи
@ru
prefLabel
Heii Arai
@ast
Heii Arai
@en
Heii Arai
@es
Heii Arai
@fr
Араи, Хэйи
@ru
新井平伊
@ja
P214
P244
P349
P106
P1814
P213
0000 0000 4650 8230
P214
P244
no2003014609
P31
P349
P569
1953-01-01T00:00:00Z
P734
P7859
lccn-no2003014609